Want to see MRVI full AI Analyst Report?
Maravai Lifesciences Holdings (MRVI) Income Statement
Maravai Lifesciences Holdings Income Statement
Last quarter (Q2 2026), Maravai Lifesciences Holdings's total revenue was $51.44M, an increase of 8.53% from the same quarter last year. In Q2, Maravai Lifesciences Holdings's net income was $-12.42M. See Maravai Lifesciences Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 185.74M | $ 259.19M | $ 288.94M | $ 883.00M | $ 799.24M | |
| $ 33.39M | $ 108.31M | $ 140.20M | $ 714.04M | $ 658.68M | |
| $ 40.13M | $ 343.93M | $ 171.85M | $ 139.83M | $ 104.03M | |
| Depreciation and Amortization | $ 60.47M | $ 56.87M | $ 48.78M | $ 38.10M | $ 24.75M |
| $ -147.51M | $ -156.92M | $ 712.41M | $ 609.99M | $ 585.78M | |
| $ -6.74M | $ -235.62M | $ -31.65M | $ 574.22M | $ 554.64M | |
| $ -228.24M | $ -25.86M | $ 649.38M | $ -22.74M | $ -23.88M | |
| $ -234.97M | $ -261.48M | $ 617.74M | $ 551.47M | $ 530.76M | |
| $ -130.77M | $ -144.85M | $ -119.03M | $ 220.21M | $ 182.04M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.91 | $ -1.05 | $ -0.90 | $ 1.67 | $ 1.59 |
| Diluted EPS | $ -0.91 | $ -1.05 | $ -0.90 | $ 1.67 | $ 1.56 |
| Weighted Average Shares Outstanding | 145.07M | 137.91M | 131.92M | 131.54M | 114.79M |
| Weighted Average Shares Outstanding (Diluted) | 145.07M | 137.91M | 131.92M | 131.69M | 121.97M |
Currency in USD